SnagRx vs Maximus: Pricing, pharmacies, and telehealth differences
Quick verdict: SnagRx vs Maximus
SnagRx is the lower-cost compounded option on a 12 month plan with a price lock at every dose, while Maximus lists a flat $132.99/month rate with prescriptions approved by licensed doctors and sourcing from trusted U.S. pharmacies. If your priority is the lowest annual compounded price and a named clinician network, SnagRx is the distinct choice; if you prefer a simple single monthly rate and broad state availability, Maximus may suit you better.
Explore SnagRx pricing and plan details
How these services compare at a glance
Both SnagRx and Maximus offer compounded semaglutide via telemedicine with U.S. pharmacies, no insurance billing, and shipping. They differ most on advertised starting price, price structure during titration, clinician network transparency, state availability, and outcome guarantees.
| Criteria | SnagRx | Maximus |
|---|---|---|
| Advertised starting price | From $69/month semaglutide on a 12 month plan | $132.99/month flat rate |
| Price structure | Rate locked flat at every dose on the 12 month plan; month to month is $99 | Low flat rate at $132.99/month |
| Clinician and pharmacy transparency | Names four US 503A partner pharmacies and OpenLoop Health clinician network | Prescriptions approved by licensed doctors; uses trusted US pharmacies |
| State availability | Clinician network covers 48 states | Available in all 50 states except Mississippi |
| Outcome or refund guarantees | Full refund if prescription declined plus a 6 month weight loss guarantee, terms apply | Full refund if not approved; no published outcome guarantee |
Price and billing: yearly plan lock versus single flat rate
SnagRx markets compounded semaglutide from $69/month on a 12 month plan and $99 month to month. The $69 figure is specifically a 12 month plan rate and SnagRx emphasizes the rate is locked flat at every dose and at renewal. Maximus markets a low flat rate at $132.99/month as its standard monthly price. Both operate on a direct pay model and state they do not bill insurance.
See Maximus pricing and availability
Clinician oversight and pharmacy sourcing
Both providers use telemedicine and U.S. pharmacies to fill compounded semaglutide. SnagRx names its four US 503A partner pharmacies and says medical care is delivered by OpenLoop Health, a network of US licensed clinicians. Maximus states prescriptions are approved by licensed doctors and filled through trusted U.S. pharmacies. SnagRx reports clinician review typically within five hours and next-day shipping when approved. Maximus highlights licensed doctor approvals and free expedited shipping.
State coverage and program limits
SnagRx notes its clinician network covers 48 states. Maximus states its weight loss protocol is available in all 50 states except Mississippi. If state availability is decisive, Maximus documents broader reach in the supplied evidence.
Confirm SnagRx state eligibility and clinician details
Guarantees, program extras, and limitations
SnagRx advertises a full refund if a prescription is declined and a 6 month weight loss guarantee, with terms applying. SnagRx also notes its compounded medications are produced in FDA regulated facilities but are not FDA approved finished products, and it urges prospective users to consult providers about risks. Maximus offers a full refund if not approved and does not publish an outcome guarantee in the supplied evidence. Both providers state they deliver compounded medication not approved as finished products by the FDA.
Direct comparison summary
In direct comparison: SnagRx is distinct for a low annual plan price and a stated price lock during titration, named 503A pharmacies, an identified clinician network, and an advertised weight loss guarantee. Maximus is distinct for a simple single monthly price of $132.99, licensed doctor approvals, trusted U.S. pharmacy fulfillment, and availability in nearly all states. Both use compounded semaglutide, telemedicine, and direct pay models, and both confirm compounded medications are not FDA approved finished products.
Start SnagRx intake or check terms
Choose SnagRx if…
You want the lowest advertised annual compounded price and a price lock across titration, prefer named US 503A partner pharmacies and an identified clinician network, and value a stated refund and a 6 month weight loss guarantee. Note the $69 rate requires the 12 month plan and medications are compounded and not FDA approved finished products.
Choose Maximus if…
You prefer a straightforward single monthly rate at $132.99 with prescriptions approved by licensed doctors, trusted U.S. pharmacy fulfillment, broader documented state availability, and a simple direct pay telemedicine workflow. Maximus also offers a full refund if you are not approved.
Both providers rely on telemedicine and compounded semaglutide supplied by U.S. pharmacies. If information is missing for a specific concern in this comparison, the supplied evidence does not include it and you should consult each provider directly.